Effects of a portacaval or peritoneovenous shunt on renin in the hepatorenal syndrome: Ten patients with hepatorenal syndrome were evaluated before and after creation of a side-to-side portacaval shunt or insertion of a peritoneovenous shunt, procedures which produced an increase in plasma volume and cardiac output. In the seven patients who survived surgery, renal function improved significantly, plasma renin activity fell from high to normal levels, and low levels of plasma renin substrate increased. Prior to surgery, blockade of angiotension II by saralasin produced hypotension and an increase in plasma renin activity, whereas after surgery, saralasin had no effect on blood pressure or renin. Our findings suggest that decreased "effective" plasma volume may be important in the stimulation of renin release and possibly in the pathophysiology of renal failure in the hepatorenal syndrome. Altered intrarenal distribution of blood flow with a relative decrease in renal cortical perfusion is a fairly common finding in patients with cirrhosis and ascites [1-31. In some cases, severe renal vaso-
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Recovery from the hepatorenal syndrome is rare. Prolonged improvement in renal function has been reported, however, in several patients following construction of a side-to-side portacaval shunt [8] [9] [10] [11] or after insertion of a peritoneovenous shunt . In this study, hemodynamic parameters and components of the renin system were measured before and after portacaval or peritoneovenous shunt surgery in ten patients with hepatorenal syndrome, seven of whom experienced significant postoperative improvement in renal function.
Methods
In the period from 1968 to 1977, patients with alcoholic cirrhosis, ascites and hepatorenal syndrome, but with evidence of good liver function, were evaluated for study. Patients with severe liver dysfunction or with gastrointestinal bleeding or other factors which may have contributed to reduced renal perfusion were excluded. Sixteen patients (representing approximately 10% of patients seen in consultation for renal failure with cirrhosis) qualified for this study. Five of these refused to participate and were treated with continuation of medical therapy. All five died of combined effects of hepatic and renal failure within one month. One patient accepted for study died before surgery was performed.
Each of the ten remaining patients who participated in the study was cachectic with massive as- Tables 1  and 2 . The creatinine clearance was less than 20 ml! mm in all but two patients, and their renal failure was not responsive to careful medical management, including plasma volume expansion with i.v. saline (from 2 to 6 liters) and albumin (from 50 to 200 g) given over 24 to 36 hours. Patients 1, 2, 4, and 5 required peritoneal dialysis to control azotemia.
Progressive weakness, anorexia, and mild to severe hepatic encephalopathy ensued in each patient, and the prognosis for prolonged survival was poor. By standard classification [16] , each of these patients was a poor surgical risk. The patients (and!or close relatives) were advised of the very high mortality rate in persistent oliguric hepatorenal syndrome and were informed of the risks inherent in the surgery, of the uncertainty of the outcome, and of the fact that the efficacy of the procedure in this setting was unproven.
Five patients (patients 1 through 5) underwent construction of a side-to-side portavacal shunt or a mesocaval shunt. In five patients (patients 6 through 10), a peritoneovenous shunt, a silastic conduit connecting the peritoneal space to the jugular vein as described by LeVeen et al [17] , was implanted to chronically transfer ascitic fluid to the venous system. In patients 6 and 9, the pentoneovenous shunt clotted after 12 weeks and 4 weeks, respectively, necessitating a second surgical procedure. A mesocaval shunt was constructed in patient 6, and another peritoneovenous shunt was placed in patient 9.
Creatinine clearance was measured on 24-hour collections of urine. Plasma renin activity (PRA) and plasma renin substrate (PRS) were measured prior to surgery after dietary intake of 10 mEq of sodium per day for 3 to 5 days and under similar conditions serially after surgery. Samples were taken in the morning with the patients supine. PRA was assayed by the method of Cohen et al [181.
Samples were collected in syringes containing ED-TA, they were chilled immediately, centrifuged at Tables  1 and 2 . In patients 2, 3, and 5, liver function worsened in the early postoperative period, and liver failure was the major cause of death. The two other patients who had portacaval shunts as the primary procedure (patients 1 and 4) are well and free of ascites 10 years and 2 years, respectively, after surgery. Each of the other five patients in whom a pentoneovenous shunt was inserted recovered from surgery without serious complication. Patient 7, however, later developed peritonitis and died 10 weeks alter surgery. In patients 6 and 9, the pentoneovenous shunt clotted, necessitating a second operation, as noted in Methods.
As shown in Table 2 , blood pressure and daily urine volume, which were low prior to surgery, increased after surgery in each patient with the exception of patient 3. Serum creatinine and blood urea nitrogen concentration decreased postoperatively in seven patients. Postoperatively, six patients underwent sustained spontaneous diuresis and natriuresis, and nine patients became responsive to diuretics. Plasma volume, measured in seven patients, rose from a preoperative mean (± SE) of 56.0 4.6 ml/kg to a postoperative value of 73.0 3.6 mllkg (P < 0.001). In each of four patients (one with a portacaval shunt and three with a pentoneovenous shunt), cardiac output rose and total vascular resistance fell following surgery (Fig. 1) .
Changes in creatinine clearance are shown in Fig.  2 . Each preoperative value represents the mean of from two to six determinations on 24-hour urine collections. Postoperative values coincide with the lat-est serum creatinine samples obtained (see Table 2 ).
In the seven patients (involving nine procedures) who recovered from surgery, creatinine clearance rose from a mean SE of 19.0 3.2 mi/mm to 68.0 7.0 mI/mm (P < 0.001). The course in patients 6 and 9 is of particular interest. In each patient, after initial improvement following insertion of the pentoneovenous shunt, the shunt clotted. Renal function deteriorated to preoperative levels (Fig. 2 , patients 6B and 9B), plasma volume and cardiac output decreased, and ascites reaccumulated ( Table 2) . Following construction of a mesocaval shunt (patient 6B) and insertion of another peritoneovenous shunt (patient 9B) renal function again improved to approximately the previous postoperative level, and ascites decreased. Witte et al [14] have reported similar findings in a patient receiving sequential peritoneovenous shunts.
Plasma renin activity (PRA) (Fig. 3) fell from a mean SE of 41.0 8.2 ng/ml/hr before surgery to 2.3 0.8 ng/ml/hr after surgery (P < 0.001). In those patients with a peritoneovenous shunt (patients 6-10), marked reduction in PRA occurred within 8 hours after surgery, whereas in those with a side-to-side portacaval shunt the changes occurred over several days to weeks. In patients 6 and 9, when the peritoneovenous shunt clotted, PRA rose, but was again suppressed to normal levels after the second surgical procedure (patients 6B and 9B). Changes in blood pressure and PRA in response to All blockade with saralasin are shown in Fig. 6 . Before surgery, each patient tested was very sensitive to All blockade, with marked hypotension occurring at doses of saralasin as low as 0.1 ,.g/kg/ mm. Postoperatively, under comparable conditions of restricted sodium intake, in each case blood pres- sure was unaffected by saralasin at a dose of up to 10 pgIkgImin. Similarly, before surgery, PRA rose during All blockade, a response similar to that seen in cirrhotics without renal failure [20] . After surgery, PRA was unaffected by All blockade.
Discussion
Renal function improved, and the renin system was significantly depressed in seven of our ten patients treated with either a portacaval shunt or a peritoneovenous shunt who survived the early postoperative period. Six of these patients are alive from 2 months to 10 years after surgery, either in improved condition or in good health. These results confirm and extend previous observations [8] [9] [10] [11] [12] [13] [14] [15] but do not establish these procedures as effective treatments for patients with hepatorenal syndrome because this was not a controlled prospective study. Our findings, along with those of others [9] [10] [11] [12] [13] [14] [15] , however, strongly suggest a causal relation between the surgical procedures and the rapid postoperative improvement in renal function. The mechanisms leading to improved renal function are not clear, and the two types of surgery may have many different physiologic effects. We focused our study on the hemodynamic effects of these shunts and coincident changes in the renin system, since circulatory changes are thought to play a major role in the hepatorenal syndrome, and All is known to be a factor in the control of peripheral vascular resistance in patients with cirrhosis and ascites [20] . In addition, All is thought to influence distribution of renal blood flow under certain circumstances [21, 221.
Plasma volume and cardiac output rose after surgery in our patients. Although preoperatively the total plasma volume and cardiac output were not low, it is possible that the arterial filling ("ef- ities between the hemodynamic and hormonal changes induced by surgery in our patients, and those induced in dogs by removal of a tight constriction on the TIVC, suggest that in the hepatorenal syndrome, as in the hemodynamically unstable dogs, decreased arterial filling is an important factor. In patients with cirrhosis and ascites, however, including our patients before surgery, plasma volume may be normal or high, and there is no correlation between total plasma volume or cardiac output and renal hemodynamic changes [2, 3] . Also, the rationale for decreased "effective" plasma volume in cirrhosis is based on the assumption that ascites forms at the expense of plasma volume. Careful studies in patients [28] and in dogs with toxic liver damage [29] , however, indicate that, at least in the early stages of cirrhosis, ascites formation results from expansion of the extracellular fluid volume, and accumulation of ascites does not compromise the "effective" plasma volume. Also, Lieberman, Ito, and Reynolds [30] Although the role of the renin system relative to renal failure in cirrhosis remains unclear, under certain conditions All is important in support of blood pressure in patients with cirrhosis [201, as shown by the preoperative response to saralasin in our patients (Fig. 6 ). In cirrhosis, however, a deficiency of plasma renin substrate (PRS), which is synthesized by the liver, may limit All production. Before surgery, PRS was below normal in all but one of our patients (Fig. 5) . A significant increase in PRS occurred shortly after surgery, and there was an inverse correlation between PRS and PRA. This suggests that in our patients with possibly limited hepatic capacity to synthesize substrate, high levels of PRA (possibly induced by renal cortical ischemia) may deplete PRS by causing a rapid rate of substrate proteolysis. Thus, a new steady state may be established wherein a low level of PRS need not be incompatible with generation of substantial amounts of All. This is consistent with the observation by Kondo et al [32] that plasma All levels in cirrhosis parallel PRA levels and may be high even in the presence of low PRS. Our data do not support the suggestion of Berkowitz, Miller, and Rosato [33] that low PRS may be a primary cause of renal vasoconstriction in the hepatorenal syndrome.
In summary, our data extend previous observations showing that improvement in renal function and normalization of the renin system occurs in some patients with hepatorenal syndrome coincident with establishing a side-to-side portacaval shunt or a peritoneovenous shunt. The efficacy of these procedures in prolonging the survival of patients with hepatorenal syndrome remains to be proven by controlled prospective study. Our study does not conclusively define whether the changes in the renin system are secondary to hemodynamic alterations or are important factors in the postoperative improvement in hemodynamic stability, nor does it provide any direct information concerning changes in intrarenal vascular resistance, which are critical in the hepatorenal syndrome. The postoperative changes noted, and the similarities between our patients with decompensated cirrhosis and TIVC dogs with low cardiac output, however, provide evidence that decreased "effective" blood volume may be important in the stimulation of renin release and possibly in the pathophysiology of renal failure in the hepatorenal syndrome.
